How to Read a Peptide Certificate of Analysis

HPLC Purity

High-performance liquid chromatography

High-performance liquid chromatography offers a comparative look at how well a peptide was synthesized by measuring the intended molecule against related chemical errors. Light sensors set to specific wavelengths calculate the percentage of the target substance relative to other organic materials produced during manufacturing. These leftovers are mostly failed versions of the peptide itself: chains that came out too short because a building block was missed, or chains that were chemically altered along the way. The resulting number grades how free the peptide is from its own synthetic byproducts. It is not a measure of every substance inside the container.

This method has real limitations. It cannot definitively name the substance, and routine HPLC with UV detection is not designed to screen for residual solvents, heavy metals, endotoxin, or microbial contamination. Some impurities also leave the column at the same moment as the target molecule, which hides them inside the main data peak. Because the result can be skewed by adjusting the sensitivity of the analysis software, a percentage with no supporting chromatogram gives an incomplete picture of product quality, and a credible vendor should be able to produce the chart on request.

A high purity rating does not mean the entire weight of the powder in a vial is active peptide. These molecules bind to stabilizing acids and absorb water from the surrounding air, and both add mass that the purity calculation never sees. A report can show near-perfect purity while the actual quantity of active substance is well below the total powder weight.

Within the broader testing hierarchy, HPLC purity sits at the foundation alongside mass spectrometry. These two answer the most basic questions about a vial, namely what the molecule is and how clean it is, and neither stands alone. The tiers above them, endotoxin and heavy metals and sterility, address a different question: not what the molecule is, but what else shares the vial with it. The pyramid reads as two layers. Identity and purity form the base, and contamination safety sits above.

Mass Spectrometry

Identity confirmation

Mass spectrometry provides the definitive identification that chromatography cannot offer on its own. In plain terms, it acts as an extremely precise scale: it weighs the molecule and checks that weight against what the peptide you ordered should weigh. Separation techniques show that a sample is mostly a single substance, but they cannot prove what that substance is. Mass spectrometry answers this by measuring the mass-to-charge ratio of the molecules, which produces a signature that, combined with fragmentation when needed, identifies the compound. The liquid sample is converted into charged gas-phase ions, often through electrospray ionization, and the equipment then weighs the molecule accurately enough to compare its measured mass against the calculated weight of the intended amino acid sequence.

Accuracy depends on the resolution of the hardware. Advanced systems measure differences in parts per million, while standard units require the observed weight to fall within a narrow band of the target, typically 0.1 to 0.5 Daltons. Knowing the total weight carries one important limit: it cannot separate different molecules that happen to weigh the same. If the amino acids are assembled in the wrong order, or if the peptide contains structural isomers such as leucine and isoleucine, the total weight stays identical. Tandem methods address the first problem by breaking the peptide into smaller fragments, which lets the instrument read the order of the building blocks along the chain. The leucine and isoleucine case is harder, because the two are identical in mass and yield the same standard fragments, so distinguishing them calls for specialized fragmentation techniques rather than a routine tandem run.

For all its strength in naming a substance, mass spectrometry is poorly suited to measuring the overall purity of a sample. Different chemical structures ionize at different rates, so a major component can appear small if it ionizes poorly, while a trace impurity can look large if it ionizes efficiently. That is the reason mass spectrometry and chromatography work as a paired, two-step check. One confirms the sample is clean and separated, the other confirms the resulting peaks are the correct peptide, and together they form the baseline for any reliable analysis.

Endotoxin (LAL Assay)

The line between injectable and not

Endotoxin testing moves past the question of what the molecule is and asks whether the vial carries a specific biological contaminant. Endotoxin is a piece of the outer wall of certain bacteria (the group known as gram-negative bacteria), and it gets released when those bacteria die and break apart. In other words, it is bacterial debris, not the live bacteria themselves. The standard assay is the LAL test, named for Limulus amebocyte lysate, which clots or changes color in the presence of endotoxin and reports a result in endotoxin units, usually as EU per milligram or EU per milliliter of product.

Sterility and endotoxin are not the same test, and conflating them is the most common error at these tiers. Sterility measures living organisms. Endotoxin measures the leftover cell-wall fragments of gram-negative bacteria that have already died. The two are independent, because endotoxin is heat-stable and survives the steps that kill bacteria. Autoclaving may kill the organisms but does not reliably eliminate their endotoxin, and a 0.22 micron sterilizing filter removes whole cells while passing endotoxin through, since the molecule is far smaller than the bacteria that produced it. A product can therefore pass sterility and still fail an endotoxin limit. Because endotoxin survives the steps that sterilize a product and can cause an acute reaction at low doses, it sits immediately above the identity and purity foundation rather than lower in the pyramid.

The harm comes in two distinct forms. A single high-dose exposure, which matters most with injection, triggers an acute pyrogenic response, meaning a fever reaction: fever, chills and shaking, and a broad inflammatory response from the immune system. At sufficient dose the same cascade can progress toward a drop in blood pressure and circulatory collapse. Repeated low-dose exposure is a separate concern and is easy to overlook, because each individual dose can stay under the threshold for an obvious reaction while still delivering endotoxin. The general principle is that endotoxin is a potent immune stimulant, so a repeated low-level load is a plausible source of ongoing immune activation rather than a harmless one. Regulatory limits are set against body weight precisely because both the acute threshold and the total load scale with the size of the person and the amount given.

Heavy Metals & Premium Tests

Pharmaceutical-grade extras

Heavy metals testing addresses another contaminant that says nothing about the molecule itself and everything about what shares the vial with it. The standard panel screens for lead, cadmium, mercury, and arsenic, the four elements that carry the most toxicological weight and that anchor the regulatory framework for elemental impurities. In peptides these metals enter through manufacturing rather than through the sequence: contaminated raw reagents, low-grade starting material, and residual metal catalysts left behind by the synthesis. None of this shows up on a purity number, which is the central point. A peptide can read 99 percent pure by HPLC and still carry a toxic metal load, because the chromatogram never measured for it.

The standard method is inductively coupled plasma mass spectrometry, ICP-MS, run at parts-per-billion sensitivity. The sample is first broken down by acid digestion, often in a high-pressure microwave, which destroys the organic peptide and leaves only the elemental metals for the instrument to read. ICP-MS is the method of record because the older technique, ICP-OES, operates at parts per million and is generally too coarse for the low limits these elements require. ICP-MS can reach parts per trillion for some elements under clean conditions, but routine COA testing works at the parts-per-billion level.

Heavy metals sit one tier apart from endotoxin because the harm follows a different clock. Endotoxin can produce an acute reaction from a single exposure. Heavy metals can behave as cumulative toxicants, often with no acute warning and no easy route of excretion, so depending on the metal, dose, route, and duration the body may store them in vital organs and the burden can grow dose by dose. Injection sharpens this. An oral contaminant has to survive the gastrointestinal tract and clear the liver before it reaches circulation, but an injected one bypasses both the gut absorption barrier and hepatic first-pass metabolism and enters the bloodstream directly. For anything injected on a repeated schedule, the absence of a heavy metals panel from a basic certificate is a real gap rather than a formality.

A premium certificate usually carries several tests beyond the identity and purity floor, and their presence signals a vendor working past the minimum. Residual solvent screening looks for leftover industrial chemicals used during synthesis (such as acetonitrile, DMF, piperidine, and TFA) that the purity test does not catch. A couple of other tests measure how much of the powder is not peptide. Water content is measured by a method called Karl Fischer titration, since freeze-dried powder pulls in moisture from the air. Counterion content measures the salt that the peptide is bound to (often TFA or acetate), using ion chromatography or a related technique. The most useful number of all is net peptide content, which is how much of the powder is actually peptide once the water and salt are subtracted. The direct way to measure it is amino acid analysis, which counts the peptide itself rather than estimating it. Put simply: amino acid analysis tells you how much real peptide you have, and the water and salt tests explain what the rest of the weight is.

Sterility

Living organisms, right now

Sterility testing asks the last of the contamination questions: whether living organisms are present in the vial right now. This is a different question from endotoxin, and the distinction matters. Endotoxin detection works backward from evidence, finding the fragments that bacteria leave behind and confirming that bacteria were present at some point, even if they are now dead. Sterility looks for organisms that are currently alive and able to multiply. The two results are independent. A vial can carry low endotoxin and still hold viable, slow-growing microbes, and it can be free of living organisms while still loaded with the dead bacterial fragments that drive a fever reaction. Neither test stands in for the other.

The reference method is USP <71>, and it amounts to a waiting game. A portion of the product is introduced into two different growth media and held for fourteen days, long enough for sparse, damaged, or slow-growing organisms to multiply to a visible level. One medium, fluid thioglycollate, is geared toward anaerobic bacteria. The other, soybean-casein digest, supports aerobic bacteria along with molds and fungi. The readout is visual: if the media stay clear through the full incubation the sample passes, and if they turn cloudy it fails. Because the full protocol is slow and costly, many labs run a faster, cheaper bioburden count or PCR screen in its place, which is not the same thing as a complete USP <71> result.

Sterility sits at the top of the pyramid, the narrowest tier, for two practical reasons. The first is cost: a full USP <71> test requires clean-room facilities and runs well above the price of the other panels. The second is that a properly controlled clean manufacturing process, usually sterile filtration or sterilization by radiation, already builds sterility into the product, so a well-made vial carries low risk before any release test is run. It is worth being clear that freeze-drying and vacuum sealing are not what make a product sterile. They preserve and protect the powder, but sterility comes from the filtration or sterilization step and the careful handling around it. The result is that sterility rarely appears on a basic research-use certificate and shows up mainly on GMP-grade material. Heat is rarely the route, since many peptides will not survive autoclaving. Note too that a 0.22 micron filter removes whole bacteria but is not a reliable endotoxin-removal filter, which is exactly why a sterile product is not automatically a low-endotoxin one.

For a self-directed user, the live-organism risk is the part that can be partly managed after the vial leaves the lab. Mixing it with bacteriostatic water at the time of use, and keeping the freeze-dried powder cold until then, both work against microbial growth, though it helps to be precise about what bacteriostatic water does. The benzyl alcohol in it slows bacterial growth in the mixed solution. It does not sterilize a contaminated vial or undo contamination that is already present. Endotoxin is the opposite case. Specialized depyrogenation methods can remove it during manufacturing, but ordinary handling will not: bacteriostatic water, cold storage, and a 0.22 micron filter do not reliably remove endotoxin once the vial is sealed, which is what makes it the number to insist on. Sterility is the premium-grade extra that most research-use buyers will never see on a certificate, while endotoxin is the contamination that ordinary end-user handling cannot correct. As the industry advances, more RUO vendors are expanding to add sterility testing (in addition to the base levels of this pyramid) and the ones that provide this level of assurance have taken the time and money to provide the user a full spectrum of information.